TrialAlzheimer's research & therapy2024

Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial.

Ivan Koychev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.